Go to main page
+§ Audited by PwC

Enzymes for feed

Sales of feed enzymes were 6% lower than in 2005, both in DKK and local currencies. The decrease was due primarily to lower prices for the phytase product group, changes in product mix and to local competition in China. Another reason for the development in 2006, which will also affect sales in the future, is the nature of Novozymes’ alliance with DSM in the feed enzyme area. Productivity improvements for new phytase products have had a negative impact on the top line, as part of the increase in productivity is shared with the partner.

Novozymes anticipates growth in sales of feed enzymes of 1-3% in 2007.

  • Novozymes’ market share: 40-45%
  • Anticipated long-term annual sales growth in local currencies: 5-10%

feed-enzymer.gif

Novozymes’ innovation to extend far and wide

Novozymes’ innovation is wide-ranging.
Read about our innovation and selected innovation projects.

Reporting Updates

"Reporting Updates" is a live reporting universe providing valuable information relevant to Novozymes' reporting several times a year.
Go to "Reporting Updates".  

Others have read